Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies

Seizure

Volumn 30, Issue , 2015, Pages 57-63

  Malter, M P ^a,d   Frisch, C ^a   Zeitler, H ^a   Surges, R ^a   Urbach, H ^b   Helmstaedter, C ^a   Elger, C E ^a   Bien, C G ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c EPILEPSY CENTER BETHEL   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Autoimmune epilepsy; GAD abs; Temporal lobe epilepsy

Indexed keywords

GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; METHYLPREDNISOLONE; NATALIZUMAB; ANTICONVULSIVE AGENT; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 2;

ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; ANTICONVULSANT THERAPY; ARTICLE; BRAIN SURGERY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOADSORPTION; IMMUNOTHERAPY; MALE; MEDICAL RECORD REVIEW; PLASMAPHERESIS; PRIORITY JOURNAL; SELECTIVE AMYGDALA HIPPOCAMPECTOMY; SINGLE DRUG DOSE; STANDARD; TEMPORAL LOBE EPILEPSY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD; CEREBROSPINAL FLUID; EPILEPSY, TEMPORAL LOBE; IMMUNOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NEUROSURGERY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTICONVULSANTS; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHILD; EPILEPSY, TEMPORAL LOBE; FEMALE; FOLLOW-UP STUDIES; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOTHERAPY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84937956720     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2015.05.017     Document Type: Article

References (44)

1. T. Chang, H. Alexopoulos, M. McMenamin, A. Carvajal-Gonzalez, S.K. Alexander, R. Deacon, and et al. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome JAMA Neurol 70 2013 1140 1149
2. J. Honnorat, A. Saiz, B. Giometto, A. Vincent, L. Brieva, A.C. de, and et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients Arch Neurol 58 2001 225 230
3. S. Mata, G.C. Muscas, I. Naldi, E. Rosati, S. Paladini, B. Cruciatti, and et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies J Neuroimmunol 199 2008 155 159
4. F. Blanc, E. Ruppert, C. Kleitz, M.P. Valenti, B. Cretin, R.L. Humbel, and et al. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J Neurol Sci 287 2009 69 71
5. M.P. Malter, C. Helmstaedter, H. Urbach, A. Vincent, and C.G. Bien Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis Ann Neurol 67 2010 470 478
6. C.I. Akman, M.C. Patterson, A. Rubinstein, and R. Herzog Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency Dev Med Child Neurol 51 2009 563 567
7. E. Haberlandt, T. Bast, A. Ebner, H. Holthausen, G. Kluger, R. Kravljanac, and et al. Limbic encephalitis in children and adolescents Arch Dis Child 96 2011 186 191
8. A. Vincent, C.G. Bien, S.R. Irani, and P. Waters Autoantibodies associated with diseases of the CNS: new developments and future challenges Lancet Neurol 10 2011 759 772
9. C. Frisch, M.P. Malter, C.E. Elger, and C. Helmstaedter Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis Eur J Neurol 20 2013 1297 1304
10. M.U. Manto, M.A. Laute, M. Aguera, V. Rogemond, M. Pandolfo, and J. Honnorat Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases Ann Neurol 61 2007 544 551
11. C. Geis, A. Weishaupt, B. Grunewald, T. Wultsch, A. Reif, M. Gerlach, and et al. Human stiff-person syndrome IgG induces anxious behavior in rats PLoS ONE 6 2011 e16775
12. C.G. Bien, A. Vincent, M.H. Barnett, A.J. Becker, I. Blumcke, F. Graus, and et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis Brain 135 2012 1622 1638
13. A. Vincent, C. Buckley, J.M. Schott, I. Baker, B.K. Dewar, N. Detert, and et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis Brain 127 2004 701 712
14. J. Dalmau, E. Tuzun, H.Y. Wu, J. Masjuan, J.E. Rossi, A. Voloschin, and et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma Ann Neurol 61 2007 25 36
15. A. Saiz, Y. Blanco, L. Sabater, F. Gonzalez, L. Bataller, R. Casamitjana, and et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association Brain 131 2008 2553 2563
16. H. Reiber, and P. Lange Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain Clin Chem 37 1991 1153 1160
17. C.G. Bien, and C.E. Elger Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life Epilepsy Behav 10 2007 529 538
18. H. Urbach Imaging of the epilepsies Eur Radiol 15 2005 494 500
19. J. Wagner, J.A. Witt, C. Helmstaedter, M.P. Malter, B. Weber, and C.E. Elger Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis J Neurol Neurosurg Psychiatry 2014 pii: jnnp-2014-307875
20. E. Langhoff, and J. Ladefoged Relative immunosuppressive potency of various corticosteroids measured in vitro Eur J Clin Pharmacol 25 1983 459 462
21. K.H. Wollinsky, M. Weindler, P.J. Hulser, P. Geiger, N. Matzek, H.H. Mehrkens, and et al. Liquorpheresis (CSF-filtration): an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain-Barre syndrome) Eur Arch Psychiatry Clin Neurosci 241 1991 73 76
22. K.H. Wollinsky, P.J. Hulser, H. Brinkmeier, P. Aulkemeyer, W. Bossenecker, K.H. Huber-Hartmann, and et al. CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial Neurology 57 2001 774 780
23. H. Clusmann, T. Kral, and J. Schramm Present practice and perspective of evaluation and surgery for temporal lobe epilepsy Zentralbl Neurochir 67 2006 165 182
24. J. Engel Jr., P.C. Van Ness, T.B. Rasmussen, and L.M. Ojemann Outcome with respect to epileptic seizures J. Engel Jr. Surgical treatment of the epilepsies 1993 Raven Press, Ltd. New York 609 621
25. P. Kwan, A. Arzimanoglou, A.T. Berg, M.J. Brodie, W.A. Hauser, G. Mathern, and et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies Epilepsia 51 2010 1069 1077
26. C. Helmstaedter, M. Lendt, and S. Lux VLMT: verbaler lern- und merkfähigkeitstest, testhandbuch 2000 Hogrefe Göttingen
27. C. Helmstaedter, C. Pohl, and C.E. Elger Eine modifizierte version des diagnostikums für cerebralschäden (DCS) zur diagnostik räumlich-visueller gedächtnisdefizite bei patienten mit temporallappenepilepsie D. Scheffner, Epilepsie 90 1991 Einhorn-Presse Reinbek 272 279
28. G. Bloomgren, S. Richman, C. Hotermans, M. Subramanyam, S. Goelz, A. Natarajan, and et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy N Engl J Med 366 2012 1870 1880
29. C.G. Bien, H. Urbach, J. Schramm, B.M. Soeder, A.J. Becker, R. Voltz, and et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy Neurology 69 2007 1236 1244
30. G. Mazzi, D.D. Roia, B. Cruciatti, S. Mata, and R. Catapano Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis Transfus Apher Sci 39 2008 229 233
31. M.S. Farooqi, Y. Lai, E. Lancaster, S.E. Schmitt, and B.S. Sachais Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response J Clin Apher 30 1 2015 8 14
32. U. Cikrikcili, C. Ulusoy, S. Turan, S. Yildiz, B. Bilgic, H. Hanagasi, and et al. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody Clin EEG Neurosci 44 2013 232 236
33. J.B. Lilleker, V. Biswas, and R. Mohanraj Glutamic acid decarboxylase (GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications Seizure 23 2014 598 602
34. M.E. Garcia Garcia, S.M. Castrillo, I.G. Morales, D. Di Capua Sacoto, and A.M. Dolado Acute amnesia and seizures in a young female Epileptic Disord 15 2013 455 460
35. Z. Georgieva, and M. Parton Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis BMJ Case Rep 2014 2014
36. A.M. Quek, J.W. Britton, A. McKeon, E. So, V.A. Lennon, C. Shin, and et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy Arch Neurol 69 2012 582 593
37. C.G. Bien, and I.E. Scheffer Autoantibodies and epilepsy Epilepsia 52 Suppl. 3 2011 18 22
38. M.C. Dalakas B cells as therapeutic targets in autoimmune neurological disorders Nat Clin Pract Neurol 4 2008 557 567
39. A. Vincent Stiff, twitchy or wobbly: are GAD antibodies pathogenic? Brain 131 2008 256 2537
40. M. Vianello, G. Bisson, M.M. Dal, S. Vassanelli, S. Girardi, C. Mucignat, and et al. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies Autoimmunity 41 2008 66 73
41. C.J. Stagg, B. Lang, J.G. Best, K. McKnight, A. Cavey, H. Johansen-Berg, and et al. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels Epilepsia 51 2010 1898 1901
42. E. Lancaster, M. Lai, X. Peng, E. Hughes, R. Constantinescu, J. Raizer, and et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen Lancet Neurol 9 2010 67 76
43. A. Boronat, L. Sabater, A. Saiz, J. Dalmau, and F. Graus GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders Neurology 76 2011 795 800
44. H. Arino, N. Gresa-Arribas, Y. Blanco, E. Martinez-Hernandez, L. Sabater, M. Petit-Pedrol, and et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy JAMA Neurol 71 2014 1009 1016